Early Clinical Data Raise the Bar for Hemophilia Gene Therapies
October 11, 2016
Several gene therapy companies reported promising early clinical data in July showing that they could restore healthy blood clotting factor levels in people with severe hemophilia.
Continue reading here.
But politics could derail the one thing to unlock it.
Enhanced cryo–electron microscopy promises to bring previously elusive proteins into view.